AVR 2.07% $17.97 anteris technologies ltd

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-262

  1. Lvd
    48 Posts.
    Untitled.jpg
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.